ALK-Abello B (ALKb)

140
-1(-0.43%)
  • Volume:
    35,681
  • Bid/Ask:
    0/0
  • Day's Range:
    140 - 142

ALKb Overview

Prev. Close
141
Day's Range
140-142
Revenue
4.05B
Open
142
52 wk Range
113-175
EPS
1.16
Volume
35,681
Market Cap
30.83B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
165,753
P/E Ratio
116.73
Beta
0.378
1-Year Change
-8.2%
Shares Outstanding
220,209,840
Next Earnings Date
10 Aug 2022
What is your sentiment on ALK-Abello B?
or
Vote to see community's results!

ALK-Abello B News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

ALK-Abello B Company Profile

ALK-Abello B Company Profile

Employees
2480
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0061802139
  • S/N:202567200

ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellSell
Technical IndicatorsStrong SellStrong SellStrong SellSellBuy
SummaryStrong SellStrong SellStrong SellSellNeutral